2. APTHOUS ULCERS
Recurrent apthous ulcers are common painful
mucosal conditions affecting oral mucosa.
The term “aphthous” is derived from a Greek word
“aphtha” which means ulceration
6. CLINICAL PRESENTATION
RAS is characterized by recurrent bouts of solitary
or multiple shallow painful ulcers
Minor RAS is also known as Miculiz's aphthae or
mild aphthous ulcers.
It is the most common variant, constituting 80% of
RAS.
Ulcers vary from 8 to 10 mm in size.
It is most commonly seen in the nonkeratinized
mucosal surfaces like labial mucosa, buccal
mucosa, and floor of the mouth.
Ulcers heal within 10–14 days without scarring.
8. CLINICAL PRESENTATION
Major RAS is also known as periadenitis mucosa
necrotica recurrens or Sutton's disease.
It affects about 10–15% of patients.
Ulcers exceed 1 cm in diameter.
Most common sites of involvement are lips, soft palate
The ulcers persist for up to 6 weeks and heal with
scarring.
9.
10. CLINICAL PRESENTATION
Herpetiform ulceration is characterized by
recurrent crops of multiple ulcers
May be up to 100 in number.
These are small in size, measure 2–3 mm in
diameter.
Lesions may coalesce to form large irregular ulcers.
These ulcers last for about 10–14 days.
13. TREATMENT OF APTHOUS ULCERS
Dietary and general measures
1. avoid spicy , hard and salty substances
2. sodium lauryl sulfate free tooth pastes
Topical therapy
1. Lidocaine as 1% cream
2. 2% gel or spray;
3. Polidocanol as paste
4. Benzocaine lozenges.
14. Antiseptics and anti-inflammatory agents
Mouth wash containing 0.15% triclosan in
ethanol and zinc sulfate
Diclofenac 3% in a 2.5% hyaluronic acid gel
Chlorhexidine mouthwash and chamomile
extract both reduced the frequency, increased
healing speed, and decreased the severity of
aphthous ulcers
15. Topical tetracycline treatment
Using a mouthwash containing chlortetracycline
2.5% increased the number of ulcer-free or pain-
free days significantly,
Tetracycline hydrochloride powder 250 mg can be
combined with 10 mL of tap water by the patient
immediately before use to avoid stabilization
problems. Because of the acid pH value, there may
be temporary mucosal burning generally followed
by clinical improvement. A stable mixture can also
be prepared by neutralizing the tetracycline
hydrochloride to create a basic product (6).
28. REITERS SYNDROME
An inflammatory arthritis of large joints,
inflammation of the eyes in the form
of conjunctivitis or uveitis, and urethritis in men
or cervicitis in women.
29.
30. CONTACT STOMATITIS
Manifested by occurrence of itching and burning
sensation
Erythema follows vesicle , erosion occurs and may
become extensive
RAS has been described under three different clinical variants as classified by Stanley in 1972
opical tetracycline treatment
Using a mouthwash containing chlortetracycline 2.5% increased the number of ulcer-free or pain-free days significantly, by 40% compared to a placebo (18) (Table 1) (EL 2A). In regards to pain reduction, a minocycline 0.2% mouthwash was superior to a tetracycline 0.25% mouthwash (19, e13) (Table 2) (EL 2A).
Tetracycline hydrochloride powder 250 mg can be combined with 10 mL of tap water by the patient immediately before use to avoid stabilization problems. Because of the acid pH value, there may be temporary mucosal burning generally followed by clinical improvement. A stable mixture can also be prepared by neutralizing the tetracycline hydrochloride to create a basic product (6).
Both a standardized formulation—as well as the less-stable freshly prepared solution—can produce rapid healing in some patients, even in those with large ulcers resistant to topical corticosteroids.
Nd yag and er yag biostimulation
Behcet's disease is a rare, chronic, lifelong disorder that involves inflammation of blood vessels throughout the body. Symptoms of Behcet's disease include recurrent oral ulcers (resembling canker sores), recurrent genital ulcers, and eye inflammation. The disorder may also cause various types of skin lesions, arthritis, bowel inflammation, and meningitis (inflammation of the membranes of the brain and spinal cord).